142 related articles for article (PubMed ID: 34392471)
21. Structural brain correlates of dementia in Huntington's disease.
Martinez-Horta S; Sampedro F; Horta-Barba A; Perez-Perez J; Pagonabarraga J; Gomez-Anson B; Kulisevsky J
Neuroimage Clin; 2020; 28():102415. PubMed ID: 32979842
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
[TBL] [Abstract][Full Text] [Related]
23. Alterations of Brain Networks in Alzheimer's Disease and Mild Cognitive Impairment: A Resting State fMRI Study Based on a Population-specific Brain Template.
Luo Y; Sun T; Ma C; Zhang X; Ji Y; Fu X; Ni H
Neuroscience; 2021 Jan; 452():192-207. PubMed ID: 33197505
[TBL] [Abstract][Full Text] [Related]
24. A more randomly organized grey matter network is associated with deteriorating language and global cognition in individuals with subjective cognitive decline.
Verfaillie SCJ; Slot RER; Dicks E; Prins ND; Overbeek JM; Teunissen CE; Scheltens P; Barkhof F; van der Flier WM; Tijms BM
Hum Brain Mapp; 2018 Aug; 39(8):3143-3151. PubMed ID: 29602212
[TBL] [Abstract][Full Text] [Related]
25. Resting-state functional magnetic resonance imaging in clade C HIV: within-group association with neurocognitive function.
du Plessis L; Paul RH; Hoare J; Stein DJ; Taylor PA; Meintjes EM; Joska JA
J Neurovirol; 2017 Dec; 23(6):875-885. PubMed ID: 28971331
[TBL] [Abstract][Full Text] [Related]
26. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease.
Vipin A; Loke YM; Liu S; Hilal S; Shim HY; Xu X; Tan BY; Venketasubramanian N; Chen CL; Zhou J
Alzheimers Res Ther; 2018 Aug; 10(1):82. PubMed ID: 30121086
[TBL] [Abstract][Full Text] [Related]
27. Cognitive impairment and structural brain changes in patients with clinically isolated syndrome at high risk for multiple sclerosis.
Hynčicová E; Vyhnálek M; Kalina A; Martinkovič L; Nikolai T; Lisý J; Hort J; Meluzínová E; Laczó J
J Neurol; 2017 Mar; 264(3):482-493. PubMed ID: 28028623
[TBL] [Abstract][Full Text] [Related]
28. Cerebral Amyloid Angiopathy Is Associated With Executive Dysfunction and Mild Cognitive Impairment.
Case NF; Charlton A; Zwiers A; Batool S; McCreary CR; Hogan DB; Ismail Z; Zerna C; Coutts SB; Frayne R; Goodyear B; Haffenden A; Smith EE
Stroke; 2016 Aug; 47(8):2010-6. PubMed ID: 27338926
[TBL] [Abstract][Full Text] [Related]
29. The Effects of an APOE Promoter Polymorphism on Human White Matter Connectivity during Non-Demented Aging.
Chang P; Li X; Ma C; Zhang S; Liu Z; Chen K; Ai L; Chang J; Zhang Z
J Alzheimers Dis; 2017; 55(1):77-87. PubMed ID: 27636845
[TBL] [Abstract][Full Text] [Related]
30. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer's disease from mild cognitive impairment.
Alegret M; Cuberas-Borrós G; Espinosa A; Valero S; Hernández I; Ruíz A; Becker JT; Rosende-Roca M; Mauleón A; Sotolongo O; Castell-Conesa J; Roca I; Tárraga L; Boada M
J Alzheimers Dis; 2014; 41(3):739-48. PubMed ID: 24685632
[TBL] [Abstract][Full Text] [Related]
31. APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease.
Morgen K; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
J Alzheimers Dis; 2013; 37(2):389-401. PubMed ID: 23948881
[TBL] [Abstract][Full Text] [Related]
32. Age-related differences in the topological efficiency of the brain structural connectome in amnestic mild cognitive impairment.
Zhao T; Sheng C; Bi Q; Niu W; Shu N; Han Y
Neurobiol Aging; 2017 Nov; 59():144-155. PubMed ID: 28882420
[TBL] [Abstract][Full Text] [Related]
33. A prospective study of neuropsychological functioning in testicular cancer patients.
Skaali T; Fosså SD; Andersson S; Cvancarova M; Langberg CW; Lehne G; Dahl AA
Ann Oncol; 2011 May; 22(5):1062-1070. PubMed ID: 21048038
[TBL] [Abstract][Full Text] [Related]
34. Long-range connections are more severely damaged and relevant for cognition in multiple sclerosis.
Meijer KA; Steenwijk MD; Douw L; Schoonheim MM; Geurts JJG
Brain; 2020 Jan; 143(1):150-160. PubMed ID: 31730165
[TBL] [Abstract][Full Text] [Related]
35. Disrupted Brain Network in Progressive Mild Cognitive Impairment Measured by Eigenvector Centrality Mapping is Linked to Cognition and Cerebrospinal Fluid Biomarkers.
Qiu T; Luo X; Shen Z; Huang P; Xu X; Zhou J; Zhang M;
J Alzheimers Dis; 2016 Oct; 54(4):1483-1493. PubMed ID: 27589525
[TBL] [Abstract][Full Text] [Related]
36. Enhanced structural connectivity within a brain sub-network supporting working memory and engagement processes after cognitive training.
Román FJ; Iturria-Medina Y; Martínez K; Karama S; Burgaleta M; Evans AC; Jaeggi SM; Colom R
Neurobiol Learn Mem; 2017 May; 141():33-43. PubMed ID: 28323202
[TBL] [Abstract][Full Text] [Related]
37.
Mirza SS; Saeed U; Knight J; Ramirez J; Stuss DT; Keith J; Nestor SM; Yu D; Swardfager W; Rogaeva E; St George Hyslop P; Black SE; Masellis M;
Neurology; 2019 Nov; 93(19):e1807-e1819. PubMed ID: 31575706
[TBL] [Abstract][Full Text] [Related]
38. Catechol-O-Methyltransferase Gene Polymorphisms and the Risk of Chemotherapy-Induced Prospective Memory Impairment in Breast Cancer Patients with Varying Tumor Hormonal Receptor Expression.
Li W; Zhao J; Ding K; Chao HH; Li CR; Cheng H; Shen L
Med Sci Monit; 2020 Sep; 26():e923567. PubMed ID: 32985495
[TBL] [Abstract][Full Text] [Related]
39. Abnormal global functional network connectivity and its relationship to medial temporal atrophy in patients with amnestic mild cognitive impairment.
Sheng C; Xia M; Yu H; Huang Y; Lu Y; Liu F; He Y; Han Y
PLoS One; 2017; 12(6):e0179823. PubMed ID: 28650994
[TBL] [Abstract][Full Text] [Related]
40. A Network of Genetic Effects on Non-Demented Cognitive Aging: Alzheimer's Genetic Risk (CLU + CR1 + PICALM) Intensifies Cognitive Aging Genetic Risk (COMT + BDNF) Selectively for APOEɛ4 Carriers.
Sapkota S; Dixon RA
J Alzheimers Dis; 2018; 62(2):887-900. PubMed ID: 29480189
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
